Low AMH Is Not the End of Your Story: What the Research Actually Shows

First: What AMH Actually Measures

Anti-Mullerian Hormone (AMH) is a protein made by the granulosa cells surrounding your growing ovarian follicles. It gives you a snapshot of your "functional ovarian reserve," meaning the pool of small growing follicles (roughly 2 to 5 mm) available for potential ovulation. Because that pool tracks with your total remaining primordial follicle count, AMH acts as an indirect gauge of how many eggs you still have in the bank.

AMH naturally falls as you age. In your early twenties it typically sits around 3.0 to 5.0 ng/mL. By your early forties it drops below 1.0 ng/mL for most women. Clinicians generally flag levels under 1.0 ng/mL as low and anything under 0.3 ng/mL as very low.

The Critical Distinction: Quantity Is Not Quality

Here is the point that matters most, and every major medical body lines up behind it.

The American Society for Reproductive Medicine (ASRM) is clear: AMH reflects "oocyte quantity" and shows only a "weak association with qualitative outcomes such as oocyte quality, clinical pregnancy rates, and live birth rates." They go further and advise that "Markers of ovarian reserve should not be used as a fertility test for women who are not infertile."

ACOG says the same thing in its own words: "Serum antimullerian hormone level assessment generally should not be ordered or used to counsel women who are not infertile about their reproductive status."

The UK's NICE guidelines cut straight to the heart of it: "Do not use AMH levels as a predictor of the likelihood of natural conception."

A useful way to frame it: AMH tells you roughly how many eggs are left in the machine. But the egg that actually gets released each month, its health, its viability, that is determined by age and quality, not by the headcount.

What the Latest Studies Show

A landmark JAMA study out of the University of North Carolina followed women aged 30 to 44 trying to conceive on their own. Among those with low AMH (below 0.7 ng/mL), 65% conceived within 6 cycles and 84% within 12 cycles. Women with normal AMH (0.7 to 8.4 ng/mL) did nearly as well: 62% in 6 cycles and 75% in 12. The difference was not statistically significant.

A 2024 study in Fertility and Sterility tracked approximately 3,150 women and found that low AMH (below 1 ng/mL) was associated with roughly 20% longer time to pregnancy on average. But women with low AMH still conceived across every cycle group they examined.

A 2024 retrospective study of 504 women landed on a blunt conclusion: "Low ovarian reserve does not influence natural conception." Low AMH showed up at similar rates in women with unexplained infertility as in fertile controls.

Then there is the 2021 meta-analysis covering 11 studies and 4,388 women. AMH's ability to predict natural conception scored an area under the curve of 0.59. Pure chance sits at 0.50. That is barely above a coin flip.

In 2025, an editorial in Fertility and Sterility went by the title "Do not measure antimullerian hormone to predict women's fecundity." The authors called routine AMH testing "inappropriate and prone to foster unwarranted anxiety."

What Reproductive Endocrinologists Say

"A low AMH result does not mean infertility," says Dr. Natalie Crawford, MD, a board-certified reproductive endocrinologist. "Whether you have 5 or 20 eggs available in a given month, your body only needs one to ovulate."

Dr. Lucky Sekhon, MD, at RMA of New York, makes the distinction plainly: "Every cycle, a woman ovulates one egg, and it's the quality of that egg, not the quantity of eggs left in the ovaries, that determines the likelihood of conception. AMH is a measure of egg quantity, not egg quality."

Dr. Monica Best at Reproductive Biology Associates adds: "Even if the AMH is less than 1 and the numbers of the eggs are low, the pregnancy rates can be perfectly reasonable, and in fact parallel to those who have better AMH levels."

Dr. Mark Trolice puts it simply: "The younger you are, irrespective of these test results, you should still have success because you still have good quality eggs."

Where AMH Does Matter

AMH does have a real job to do. It predicts how your ovaries will respond to IVF stimulation medications. If you are planning IVF or egg freezing, the number of eggs retrieved per cycle correlates with your AMH. Lower AMH usually means fewer eggs per retrieval, which can influence how many cycles you might need.

But even in that context, low AMH does not write the end of the story. A major study from the SART database covering over 5,000 IVF cycles found that patients with ultra-low AMH (0.16 ng/mL) still achieved 13% clinical pregnancy rates per cycle start and 20% live birth rates per transfer.

The ASRM states it explicitly: "Extremely low AMH values should not be used to refuse treatment in IVF."

What You Can Do

Support egg quality through lifestyle: Since quality outweighs quantity, focus your energy on what you can actually move. Egg quality is shaped by mitochondrial health, oxidative stress levels, and overall metabolic function.

• CoQ10 supplementation (400 to 600 mg/day): A randomized controlled trial found that 600 mg/day for 60 days before IVF significantly improved oocyte yield, fertilization rates, and embryo quality in women with diminished ovarian reserve. CoQ10 is an essential cofactor for mitochondrial energy production, and your oocytes are among the most mitochondria-dense cells in your entire body.
• DHEA (75 mg/day, physician-supervised): Studies have shown AMH concentrations improved by approximately 60% and mature follicle percentage rising from 54% to 72% with supplementation. This is a hormone, so medical supervision is essential.
• Vitamin D: A prospective cohort study found live birth rates varied sharply by vitamin D status: deficient 23.2%, insufficient 27.0%, replete 37.7%. Aim for serum levels of 30 to 50 ng/mL.
• Stress management: The LIFE study found that women with high salivary alpha-amylase (a stress biomarker) had a 29% decrease in fecundity and more than double the risk of infertility. Mindfulness-based stress reduction programs show consistent psychological benefits, and Dr. Alice Domar's Mind/Body Program found pregnancy rates of 52% in the intervention group versus 20% in controls during IVF.
• Mediterranean diet: Higher adherence is associated with 65 to 68% greater likelihood of IVF success. In overweight women, higher adherence to a profertility diet was associated with AMH concentrations 1.45 to 1.67 ng/mL higher than the lowest adherence group.
• Exercise: Moderate activity (about 5 hours per week of brisk walking) was associated with shorter time to conception. Vigorous activity beyond 5 hours per week may actually reduce fecundity in normal-weight women.
• Sleep: 7 to 8 hours is the sweet spot. Women who reported difficulty falling asleep more than three times a week had significantly reduced blastocyst rates in IVF.

Real Stories, Real Hope

Dr. John Preston Parry, a reproductive endocrinologist, shares that his own wife conceived their youngest child with an AMH of approximately 0.3. That is a level many clinicians would label very low.

An RMA Network study found no difference in pregnancy rates between women with normal AMH and women with low AMH who were trying to conceive naturally.

Women in fertility communities regularly report conceiving with AMH levels below 0.5. One documented case involved conception with an AMH of 0.01 and FSH of 150, numbers that would typically point toward primary ovarian insufficiency.

When to See a Specialist

If you have been trying to conceive for 12 months (under 35) or 6 months (over 35) without success, or if you carry risk factors like a family history of early menopause, prior ovarian surgery, or endometriosis, it makes sense to see a reproductive endocrinologist. A full fertility workup includes AMH alongside FSH, estradiol, antral follicle count, tubal assessment, and male factor evaluation. No single number tells the whole story.

If a provider tells you there is nothing they can do based solely on your AMH, get a second opinion. Multiple reproductive endocrinologists stress that low AMH should prompt proactive planning, not a sense of finality.

The Emotional Weight of a Number

Research shows that up to 40% of women experiencing infertility carry a psychiatric diagnosis, most often depression or anxiety. A low AMH result can hit hard emotionally, especially when the clinical context is not fully explained to you.

Dr. Sekhon warns that patients often receive "devastating predictions based solely on AMH without considering other fertility factors," causing unnecessary harm. If a low AMH result has you struggling emotionally, consider connecting with a fertility-focused therapist. The American Society for Reproductive Medicine recommends that all practices offering assisted reproduction have access to mental health professionals who specialize in fertility counseling.

Your AMH is one data point among many. It is not a verdict. Age, egg quality, overall health, and factors we do not yet fully understand all shape your fertility story. The science is clear: a low number does not mean the end of hope.

This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider for guidance specific to your situation.